Physician profile
Brent Taylor
NPI 1316175128
$1,633.48
in general payments reported to CMS, 2019-2025
20 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $81.80 · 2021: $162 · 2022: $445 · 2023: $284 · 2024: $190 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.98 | 2019-2025 | Botox, Rinvoq |
| Genzyme Corporation | $269.39 | 2021-2025 | |
| Ucb, INC. | $172.10 | 2022-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $148.73 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Regeneron Healthcare Solutions, INC. | $146.31 | 2021-2024 | Dupixent |
| Incyte Corporation | $88.90 | 2021-2022 | |
| Janssen Biotech, INC. | $86.20 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $76.11 | 2021-2024 | Olumiant |
| Dermavant Sciences, INC. | $59.96 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $40.80 | 2023-2024 | Zoryve |
| Almirall LLC | $34.07 | 2019-2022 | |
| Galderma Laboratories, L.P. | $33.89 | 2021-2025 | Nemluvio |
| Organon LLC | $31.25 | 2025 | |
| Mayne Pharma Commercial LLC | $30.76 | 2020 | |
| Epi Health, LLC | $30.53 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $25.66 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Novartis Pharmaceuticals Corporation | $23.67 | 2019 | |
| Biofrontera INC. | $23.05 | 2021 | |
| Allergan, INC. | $16.73 | 2020 | |
| Aclaris Therapeutics, INC. | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.